According to IQVIA, the European market for Buprenorphine-based opioid dependency treatments in 2023 surpassed USD 355 million annually
The certification marks a new chapter in Windlas Biotech’s growth trajectory,
Increases speed to market for drug developers working on nucleic acid therapeutics
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
The cornerstone of the quality ecosystem is the implementation of the Quality Control Orders
40th DSIR Foundation Day celebration marks 16 more technology transfers from CSIR to MSMEs
Parkinson's disease (PD) is one of the most common neurological disorders caused by the death of dopamine-secreting neurons in the brain
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
SynerK owns intellectual property rights of SNK-2726, which is currently in the IND filing preparation stage
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Subscribe To Our Newsletter & Stay Updated
